NCT05306444View on ClinicalTrials.gov

CLN-418 Study on Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

August 28, 2024

Study Completion Date

September 10, 2024

Conditions
Advanced Solid Tumor
Interventions
DRUG

CLN-418

Intravenous (IV) administration

Trial Locations (7)

2217

St George Private Hospital, Kogarah

2500

Southern Medical Day Care Centre, Wollongong

28078

Carolina BioOncology Institute - Cancer Research Centre, Huntersville

34232

Florida Cancer Specialists, Sarasota

75039

NEXT Oncology, Irving

77030

MD Anderson, Houston

90033

USC Norris Comprehensive Cancer Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Harbour BioMed US, Inc.

INDUSTRY